| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |